Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Reexamination Certificate
2005-05-17
2005-05-17
Leith, Patricia (Department: 1654)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
Reexamination Certificate
active
06893627
ABSTRACT:
The present invention provides materials and methods relating to mildly polar fluid extracts of plant materials, such asArtemisiaplant species, useful in methods for treating diabetes and methods for modulating the activity of glucagon-like peptide-1 (GLP-1), and in methods for modulating phosphoenol pyruvate carboxykinase (PEPCK) activity in a diabetes-specific manner. The extracts are generally non-toxic and non-mutagenic and may be administered to diabetics with beneficial effect on blood glucose levels. The extracts may also be administered to non-diabetics without deleterious effect. The plants are easily grown with a minimum of time, labor, and cost. Extracts are inexpensively and quickly prepared without the need for fractionation to remove potentially deleterious compounds, and the extracts may be administered to mammals such as humans through various routes, in a variety of forms, and at convenient concentrations.
REFERENCES:
patent: 4534317 (1985-08-01), Walsh et al.
patent: 6096364 (2000-08-01), Bok et al.
patent: 6251380 (2001-06-01), Jo
patent: WO 9735598 (1997-10-01), None
patent: WO 0015174 (2000-02-01), None
Subramoniam et al. Effects of Artemisia Pallens Wall. On Blood Glucose Levels in Normal and Alloxan-Induced Diabetic Rats; Jornal of Ethanopharmacology 50 (1996) 13-17.*
International Search Report, United States Patent and Trademark Office, Jan. 14, 2003.
Al-Waili et al., “Treatment of Diabetes Mellitus byArtemisia Herba-AlbaExtract: Preliminary Study.” Clinical and Experimental Pharmacology and Physiology 13:569-573 (1986).
Ames et al., “Methods for Detecting Carcinogens and Mutagens with the Salmonella/Mammalian-Microsome Mutagenicity Test.” Mutation Res. 31:347-364 (1975).
Drucker, “Glucagon-Like Peptides,” Diabetes 47:159-169 (1998).
Fehmann et al., “Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-and Glucose-Dependent Insulin Releasing Polypeptide,” Endocr. Rev. 16:390-410 (1995).
Henry et al., “Insulin Action and Glucose Metabolism in Nondiabetic Control and NIDDM Subjects.” Diabetes 44:936-946 (1995).
Koch et al., “Partial Purification of the Solubilized Insulin Receptor from Rat Liver Membranes by Precipitation with Concanavalin A,” Hoppe-Syler's Z. Physiol. Chem. 362, S:347-351 (1981).
Luna et al., “Oral Agents in the Management of Type 2 Diabetes Mellitus.” Am. Fam. Physician 63:1747-1756 (2001).
Piller et al., “Properties and stabilization of an extracellular α-glucosidase from the extremely thermophilic archaebacteriaThermocccusstrain AN1:enzyme activity at 130° C.,” Biochimica et Biophysica Acta 1292:197-205 (1996).
Rodbell, “Metabolism of Isolated Fat Cells,” J. Biol. Chem. 239:375-380 (1964).
Sandhu et al., “Glucagon-Like Peptide 1 Increases Insulin Sensitivity in Depancreatized Dogs,” Diabetes 48:1045-1053 (1999).
Shimura et al., “Docosahexanoic Acid (DHA) Improved Glucose and Lipid Metabolism in KK-AyMice with Genetic Non-Insulin-Dependent Diabetes Mellitus (NIDDM),” Biol. Pharm. Bull. 20:507-510 (1997).
Suto et al., “Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Aymice,” Euro. J. Endocrin. 139:654-661 (1998).
Swanston-Flatt et al., “Evaluation of Traditional Plant Treatments for Diabetes Studies in Streptozotocin Diabetic Mice,” Acta Diabetol. Lat. 26:51-55 (1989).
Swanston-Flatt et al . “Traditional dietary adjuncts for the treatment of diabetes mellitus,” Proc. Nutr. Soc. 50:641-651(1991).
Tokunaga et al., “Streptozotocin-Induced Elevation of Pancreatic Taurine Content and Suppressive Effect of Taurine on Insulin Secretion,” European J. of Pharmacol. 87:237-243 (1983).
Wang et al., “Glucagon-like Peptide-1 Regulates the Beta Cell Transcription Factor, PDX-1, in Insulinoma Cells,” Endocrinology 140:4904-4907 (1999).
Yazdanparast et al., “Effects of aqueous tarragon,Artemisia dracunculus, extract on lipid and coagulatory parameters in rats,” Biomedical Letters 59:137-141 (1999).
Raskin Ilya
Ribnicky David M.
Leith Patricia
Marshall & Gerstein & Borun LLP
Rutgers The State University of New Jersey
LandOfFree
Method for treating type 2 diabetes with an extract of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating type 2 diabetes with an extract of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating type 2 diabetes with an extract of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3369241